Your session is about to expire
← Back to Search
Cognitive Assessment for Liver Surgery Patients
N/A
Recruiting
Led By Timothy Newhook, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All English-speaking patients undergoing hepatectomy at main campus University of Texas (UT)-MD Anderson Cancer Center who are cognitively able to provide informed consent in the opinion of the attending physician
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial is testing how well electronic neurocognitive tools can screen for mental capability in patients who are undergoing liver surgery. The hope is that these tools will be able to better assess mental impairment.
Who is the study for?
This trial is for English-speaking patients at UT-MD Anderson Cancer Center who are about to have liver surgery and can give informed consent. It's designed to see if they're mentally sharp enough for the procedure.Check my eligibility
What is being tested?
The study is testing electronic tools called BrainCheck Cognitive Assessment to screen mental capability in patients before liver surgery, aiming to identify any cognitive impairments more effectively.See study design
What are the potential side effects?
Since this trial involves non-invasive cognitive assessments, there are no direct physical side effects expected from participating in the study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average time to complete the BrainCheck battery
Average time to complete the pen and paper assessment
Completion rate of the BrainCheck battery
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (BrainCheck and paper and pen cognitive assessment)Experimental Treatment2 Interventions
Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen assessment 2 months prior to surgery and within 2 months after surgery.
Group II: Group II (pen and paper and BrainCheck cognitive assessment)Active Control2 Interventions
Patients receive the paper and pen assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BrainCheck Cognitive Assessment
2020
N/A
~40
Cognitive Assessment
2011
Completed Phase 2
~1320
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,973 Previous Clinical Trials
1,789,290 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,754 Total Patients Enrolled
Timothy Newhook, MDPrincipal InvestigatorM.D. Anderson Cancer Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this investigation have any openings for new participants?
"According to clinicaltrials.gov, this medical experiment is searching for participants. This trial was first launched on August 17th 2018 and has been amended most recently on September 22nd 2022."
Answered by AI
How many participants have been recruited for this trial thus far?
"Affirmative. The information found on clinicaltrials.gov shows that this study, which was first posted back in August 2018, is currently accepting participants. Approximately 100 individuals will be required to take part across 1 site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger